Accelerate Diagnostics, Inc. (AXDX) Social Stream

Accelerate Diagnostics, Inc. (AXDX): $5.61

0.33 (+6.25%)

POWR Rating

Component Grades









Use the tables below to see what analysts covering ACCELERATE DIAGNOSTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 2 $7 $7 $7 $5.466 28.06%
2022-03-09 3 $5 $5 $5 $5.466 -8.53%
NA 1 $NA $NA $NA $5.466 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target

AXDX's average price target has moved down $7.33 over the prior 48 weeks.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

AXDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 1 0 1 1 1 3

The Trend in the Broker Recommendations

Over the past 151 days, AXDX's average broker recommendation rating improved by 0.4.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AXDX as an investment opportunity.

  • AXDX has a greater number of analysts covering the stock than 25.11% of all US stocks.
  • In the context of all US stocks, ACCELERATE DIAGNOSTICS INC's variance in analysts' estimates is lower than just about 100% of them.
  • In the context of Measuring and Control Equipment stocks, ACCELERATE DIAGNOSTICS INC's average analyst price target is greater than 21.56% of them.
  • ACCELERATE DIAGNOSTICS INC's upside potential (average analyst target price relative to current price) is higher than 58.12% of stocks in the small market cap category.

Stocks similar to ACCELERATE DIAGNOSTICS INC in the Measuring and Control Equipment industry regarding analyst recommendations and price targets are NAUT, PRE, and OMIC.

Is AXDX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!